As an oncogene, CCND1 was shown to promote tumor growth by regulating cyclin-dependent kinase 4 (CDK4), through modulating the cell cycle transtion from the G1 to the S phase, thereby making CCND1 and its regulatory partner, CDK4, attractive potential therapeutic targets [14]. This evidence concerns the gene CCND1 and neoplasm.